menu
    • menu

    Company profile for Intravacc

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Intravacc is an experienced R&D organization with a proven track record in vaccinology of over 100 years. We have a wide range of expertise to independently develop vaccines from lead concept to clinical phase I/II studies as wel as our own product pipeline and patents. a wide range of science-based, one-stop-shop solutions, state-of-the-art facilities on site, Bacterial and Viral vaccines, OMV technology, Vero cell platforms,...
    Intravacc is an experienced R&D organization with a proven track record in vaccinology of over 100 years. We have a wide range of expertise to independently develop vaccines from lead concept to clinical phase I/II studies as wel as our own product pipeline and patents. a wide range of science-based, one-stop-shop solutions, state-of-the-art facilities on site, Bacterial and Viral vaccines, OMV technology, Vero cell platforms, Innovative vaccine design, 3R research

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IntravaccNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Antonie van Leeuwenhoeklaan 9, 3721 MA, Bilthoven
    Telephone
    Telephone
    +31 30 7920 300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.intravacc.nl/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intravacc and Primrose Bio Partner to Enhance Conjugate Vaccine Development
    Intravacc and Primrose Bio Partner to Enhance Conjugate Vaccine Development

    28 Mar 2024

    // BIOSPACE

    https://www.biospace.com/article/releases/intravacc-and-primrose-bio-announce-partnership-to-enhance-conjugate-vaccine-development/

    BIOSPACE
    28 Mar 2024
    Share Share
    Intravacc and Primrose Announce Partnership to Enhance Conj Vaccine Development
    Intravacc and Primrose Announce Partnership to Enhance Conj Vaccine Development

    28 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/28/2853733/0/en/Intravacc-and-Primrose-Bio-Announce-Partnership-to-Enhance-Conjugate-Vaccine-Development.html

    GLOBENEWSWIRE
    28 Mar 2024
    Share Share
    Intravacc Reports Positive Data For Intranasal OMV SARS-CoV-2 Vaccine
    Intravacc Reports Positive Data For Intranasal OMV SARS-CoV-2 Vaccine

    26 Mar 2024

    // PRESS RELEASE

    https://www.intravacc.nl/company/news-events/news-article-view?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=64&cHash=6d429252b39f046658cd623ab4d2c1fb

    PRESS RELEASE
    26 Mar 2024
    Share Share
    Intravacc announces positive data of intranasal OMV based vaccine for SARS-CoV-2
    Intravacc announces positive data of intranasal OMV based vaccine for SARS-CoV-2

    26 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/26/2852111/0/en/Intravacc-announces-positive-data-of-first-in-human-intranasal-OMV-based-vaccine-for-SARS-CoV-2.html

    GLOBENEWSWIRE
    26 Mar 2024
    Share Share
    Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine
    Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine

    16 Jan 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/01/16/2809631/0/en/Intravacc-Awarded-US-633K-CARB-X-Funding-to-Develop-a-Vaccine-that-Prevents-Gonorrhea-Infections.html

    GLOBENEWSWIRE
    16 Jan 2024
    Share Share
    Intravacc Gets $633K CARB-X Funding For Gonorrhea Vaccine Development
    Intravacc Gets $633K CARB-X Funding For Gonorrhea Vaccine Development

    11 Jan 2024

    // PRESS RELEASE

    https://www.intravacc.nl/company/news-events/news-article-view?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=60&cHash=2ea3e7d7c72798c240e9295961892c20

    PRESS RELEASE
    11 Jan 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search